Cognition Therapeutics (CGTX) Other Non-Current Assets (2022 - 2023)
Cognition Therapeutics (CGTX) posted quarterly Other Non-Current Assets of $1.8 million for Q3 2023, up 3.97% year-over-year from $1.7 million in Q3 2022, and up 23.16% quarter-over-quarter from $1.4 million in Q2 2023.
Cognition Therapeutics (CGTX) Other Non-Current Assets (2022 - 2023) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Other Non-Current Assets for 2 consecutive years, with $1.8 million the latest figure, recorded in Q3 2023.
- In Q3 2023, Other Non-Current Assets rose 3.97% year-over-year to $1.8 million; the TTM figure through Sep 2023 stood at $1.8 million (up 3.97% YoY), while the FY2022 annual figure was $1.7 million, changed N/A from the prior year.
- Other Non-Current Assets advanced to $1.8 million in Q3 2023 per CGTX's latest filing, from $1.4 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.8 million in Q1 2023 and bottomed at $1.3 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 1.69 Mn |
| Jun 30, 2022 | 1.29 Mn |
| Mar 31, 2022 | 1.42 Mn |